Kimia Biosciences gets permission to manufacture, market ‘Fimasartan Potassium Trihydrate API’
23rd Jul 2020

Kimia Biosciences has been granted permission to manufacturing and marketing of new active pharmaceutical Ingredient ‘Fimasartan Potassium Trihydrate API’ by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare.

Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.